ENGOT-en9/LEAP-001: A phase III study of first-line pembrolizumab plus lenvatinib versus chemotherapy in advanced or recurrent endometrial cancer.
Tarih
2020Yazar
Marth, Christian
Vulsteke, Christof
Perez, Maria Jesus Rubio
Makker, Vicky
Braicu, Elena Ioana
McNeish, Iain A.
Madry, Radoslaw
Ayhan, Ali
Hasegawa, Kosei
Wu, Xiaohua
Dutta, Lea
Xu, Cindy
Keefe, Stephen Michael
Lee, John J.
Pignata, Sandro